New drug application: Difference between revisions

From DISI
Jump to navigation Jump to search
No edit summary
m (2 revisions)
 

Latest revision as of 20:31, 8 October 2012

A new drug application (NDA) is an application submitted by the manufacturer of a drug to the FDA - after clinical trials have been completed - for a license to market the drug for a specified indication.